Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C

Stem Cell Res. 2022 Aug:63:102834. doi: 10.1016/j.scr.2022.102834. Epub 2022 Jun 6.

Abstract

The phospholamban (PLN) R14del mutation is associated with arrhythmogenic right ventricular dysplasia (ARVD/C). ARVD/C is a cardiac disease characterized by arrhythmias and structural abnormalities in the right ventricle. Because PLN is a regulator of calcium release, this mutation can have deleterious effects on tissue integrity and contraction. This mutation is a trinucleotide (AGA) deletion that leads to an arginine deletion at position 14 of the PLN structure. Here we show two lines carrying this mutation with typical iPSC morphology, pluripotency, karyotype, ability to differentiate into the three germ layers in vitro, and readily availability for studying pathological mechanisms or ARVD/C.

Keywords: Arrhythmogenic right ventricular dysplasia; Induced pluripotent stem cells; PLN.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Arrhythmogenic Right Ventricular Dysplasia* / genetics
  • Calcium-Binding Proteins* / genetics
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation / genetics

Substances

  • Calcium-Binding Proteins
  • phospholamban